Multiple Sclerosis Management Concepts

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What demographic is most commonly affected by Multiple Sclerosis?

Ages 40-60

Ages 20-40 (correct)

Ages 10-20

Ages 60 and above

What is the male to female ratio typically found in Multiple Sclerosis cases?

1:2

2:1

1.5-3:1 (correct)

1:1

Which of the following factors is NOT associated with the etiology of Multiple Sclerosis?

Infections

Environmental factors

Genetics

Trauma to the spinal cord (correct)

What is the estimated annual cost for treating a patient with Multiple Sclerosis in the USA?

$9,000 - $50,000 Signup and view all the answers

At what age is the critical migration period that affects the prevalence of Multiple Sclerosis?

14 Signup and view all the answers

What role does Vitamin D play in Multiple Sclerosis according to expert consensus?

It is an immune modulator and gene regulator. Signup and view all the answers

What percentage of concordance is observed in monozygotic twins regarding Multiple Sclerosis susceptibility?

30% Signup and view all the answers

How is the relationship between low Vitamin D levels and Multiple Sclerosis best described?

Lower levels increase lesion load and progression. Signup and view all the answers

What characterizes the immune aspect of multiple sclerosis (MS)?

An imbalance between immunoregulatory and proinflammatory immune cells Signup and view all the answers

Where do plaques typically form in the brains of individuals with MS?

Around veins in the brain Signup and view all the answers

Which sign is commonly associated with optic neuritis in MS?

Pain on eye movement Signup and view all the answers

What is essential for the diagnosis of MS based on the provided criteria?

Dissemination in time and space Signup and view all the answers

What symptom is associated with spinal cord syndrome in MS?

Lhermitte’s symptom Signup and view all the answers

Which of the following describes acute transverse myelitis in the context of MS?

It is usually a partial involvement of the cord Signup and view all the answers

What is the mean age of onset for Primary Progressive MS (PPMS)?

50s Signup and view all the answers

Which subtype of MS accounts for approximately 15% of cases?

Primary Progressive MS Signup and view all the answers

Which of the following is a symptom commonly associated with the cerebral hemispheres in MS?

Cognitive impairment Signup and view all the answers

The McDonald criteria for MS diagnosis includes which components?

Clinical assessment and MRI findings alongside ancillary tests Signup and view all the answers

What distinguishes Secondary Progressive MS (SPMS) from other forms?

Progressive myelopathy after a certain distance Signup and view all the answers

Which statement regarding the clinical presentation of MS is correct?

Acute attacks usually last more than 24 hours Signup and view all the answers

Which treatment is currently approved for Primary Progressive MS?

Ocrelizumab Signup and view all the answers

What is required for the diagnosis of PPMS along with one year of disease progression?

Evidence of dissemination in space on MRI Signup and view all the answers

What characterizes Clinically Isolated Syndrome (CIS)?

First episode of demyelination Signup and view all the answers

What percentage of patients with CIS convert to clinically definite MS (CDMS) within 20 years?

80% Signup and view all the answers

What percentage of patients with RIS is likely to progress radiologically within 5 years?

60% to 70% Signup and view all the answers

Which treatment is administered for acute attacks in MS?

Methylprednisolone Signup and view all the answers

Which of the following statements about 'Shift early' in MS treatment is true?

It prioritizes aggressive treatment after the first attack. Signup and view all the answers

What is indicated by the term NEDA-4 in Multiple Sclerosis treatment?

All of the above Signup and view all the answers

What is the main outcome of using Interferon Beta1 in MS treatment?

Reduction of annual relapse rate by 30% Signup and view all the answers

Which of the following is NOT classified as a symptomatic treatment for MS?

Natalizumab Signup and view all the answers

How many patients with RRMS can expect to be wheelchair-bound after 10 years of diagnosis?

40-50% Signup and view all the answers

Which drug among the following is classified as a sphingosine-1-phosphate receptor modulator?

Fingolimod Signup and view all the answers

What is the primary mode of administration for Natalizumab?

Injectable every 4 weeks Signup and view all the answers

What is a common safety issue associated with Fingolimod?

PML and serious infections Signup and view all the answers

What is a notable side effect of Teriflunomide?

Alopecia and non-life threatening infections Signup and view all the answers

Which MS treatment is known for a 5-day infusion followed by a 3-day infusion after 12 months?

Alemtuzumab Signup and view all the answers

What is Cladribine classified as?

Chemotherapeutic agent Signup and view all the answers

What kind of medications are SIPONIMOD and FINGOLIMOD considered?

S-1-P modulators Signup and view all the answers

What does the annual relapse rate reduction for Dimethyl fumarate approximate?

45% Signup and view all the answers

What aspect of COVID-19 was found to be worse in MS patients with higher disability?

Prognosis of COVID-19 infection Signup and view all the answers

What is the primary characteristic of Multiple Sclerosis?

Demyelination and neuroinflammation Signup and view all the answers

Which factors contribute to the multifactorial etiology of Multiple Sclerosis?

Genetics and environmental triggers Signup and view all the answers

Why are individuals born in November less affected by Multiple Sclerosis than those born in May?

Seasonal variations in sunlight exposure Signup and view all the answers

What is the role of Vitamin D in relation to Multiple Sclerosis according to expert opinions?

Vitamin D functions as an immune modulator and gene regulator Signup and view all the answers

What percentage concordance is observed in dizygotic twins concerning Multiple Sclerosis susceptibility?

5 percent Signup and view all the answers

What critical factor is related to the Epstein-Barr virus in the context of Multiple Sclerosis?

Infection should happen at a critical time in susceptible individuals Signup and view all the answers

Which statement accurately reflects the geographical distribution of Multiple Sclerosis prevalence?

Increased prevalence away from the equator Signup and view all the answers

What conclusion can be drawn about the economic burden associated with Multiple Sclerosis?

Annual treatment costs range from $9,000 to $50,000 Signup and view all the answers

What structures in the brain are primarily affected by demyelination in Multiple Sclerosis?

Grey matter Signup and view all the answers

Which symptom is most characteristic of optic neuritis in Multiple Sclerosis?

Red vision affected first Signup and view all the answers

What type of signs might you observe in a patient with brain stem syndrome due to Multiple Sclerosis?

Diplopia and ataxia Signup and view all the answers

In the context of Multiple Sclerosis, what does acute transverse myelitis usually present as?

Partial involvement, rarely exceeding three adjacent segments Signup and view all the answers

Which type of immune cells are predominantly involved in the formation of MS plaques?

Lymphocytes and macrophages Signup and view all the answers

Which symptom is associated with spinal cord syndrome in Multiple Sclerosis?

Clonus Signup and view all the answers

What characteristic does the McDonald criteria for diagnosing Multiple Sclerosis include?

A combination of clinical, MRI, and ancillary tests Signup and view all the answers

What does Lhermitte's symptom indicate in a patient with Multiple Sclerosis?

Shock-like sensations down the spine Signup and view all the answers

What key feature distinguishes Clinically Isolated Syndrome (CIS) from other forms of Multiple Sclerosis?

It represents the first episode of demyelination. Signup and view all the answers

Which factor is a crucial component of the diagnostic criteria for Primary Progressive MS (PPMS)?

Evidence of dissemination in space (DIS) on MRI. Signup and view all the answers

What is the primary method of classifying Secondary Progressive MS (SPMS) activity?

MRI activity and presence of relapses. Signup and view all the answers

Which statement is true regarding the age of onset for Primary Progressive MS (PPMS)?

The mean age of onset is in the 50s. Signup and view all the answers

Which treatment has been approved specifically for Secondary Progressive MS (SPMS)?

Siponimod Signup and view all the answers

What percentage of patients with Clinically Isolated Syndrome (CIS) is likely to convert to clinically definite Multiple Sclerosis (CDMS) within 2 years?

60 percent Signup and view all the answers

What is a common symptom associated with Secondary Progressive MS (SPMS)?

Ambulatory dysfunction becomes evident. Signup and view all the answers

What does the term 'Dawson fingers' refer to in the context of MS?

A pattern of lesions in the corpus callosum observed on MRI. Signup and view all the answers

What is the estimated percentage of individuals who will be disabled and dependent 25 years post-diagnosis of Relapsing-Remitting Multiple Sclerosis (RRMS)?

75-90 percent Signup and view all the answers

Which treatment strategy indicates no new or enlarging T2 lesions, no confirmed clinical relapses, no 6 months of disability progression, and an annual brain atrophy rate below 0.4%?

NEDA-4 Signup and view all the answers

What is the primary reason behind the recommended strategy of 'hit strong from the start' in MS treatment?

To prevent silent progression Signup and view all the answers

Which of the following is a common treatment for symptomatic spasticity in MS patients?

Baclofen Signup and view all the answers

What is the reduction in the annual relapse rate associated with Interferon Beta1 treatment?

30 percent Signup and view all the answers

Which medication is categorized under symptomatic treatments for pain in MS?

Duloxetine Signup and view all the answers

What is the goal of the 'wait and see' strategy in MS treatment?

To delay treatment until significant lesions appear Signup and view all the answers

Which population is identified as being more likely to benefit from timely treatment during the First Clinical Demyelinating Event?

Patients diagnosed with CIS Signup and view all the answers

What is the primary mechanism of action for Fingolimod?

S-1-P modulation Signup and view all the answers

Which of the following side effects is associated with Teriflunomide?

Non-life threatening infections Signup and view all the answers

What is a notable benefit of Natalizumab in terms of relapse rates?

Annual relapse rate reduction by 68% Signup and view all the answers

Which statement accurately describes the safety profile of Cladribine?

Side effects primarily involve cytopenia and infection Signup and view all the answers

What is the dosing regimen for Ocrelizumab used in treating MS?

Every 6 months IV infusion Signup and view all the answers

Which of the following treatments is considered an infusion therapy?

Alemtuzumab Signup and view all the answers

What is the main concern regarding the safety of Natalizumab?

Progressive multifocal leukoencephalopathy (PML) Signup and view all the answers

What characterizes the treatment approach of SIPONIMOD in comparison to Fingolimod?

Identical mechanism and efficacy Signup and view all the answers

Study Notes

Multiple Sclerosis: Concepts and Update on Management

Multiple Sclerosis (MS) is an autoimmune inflammatory disorder of the central nervous system (CNS)
Etiology is unknown, characterized by demyelination and axonal loss
Age of onset is typically 20-40
Females are affected 1.5-3 times more often than males
MS is the second most common disabling disease in the USA
Globally, 2.8 million are affected (underestimate)
Costs range from 9,000to9,000 to 9,000to50,000 USD per patient annually
High rate of unemployment as disease progresses
Etiology: Multifactorial, involving genetics, infection, geography, climate, environment, nutrition, and smoking

Geography and Climate

Increased prevalence away from the equator
Exceptions exist
Critical migration age is 14-15
Those born in November are less affected than those born in May

Epidemiology

Age 20-40.
Female:Male is 1.5-3:1

Etiology

Multifactorial
Interplay of Genetics-Infection-Geography-Climate-Environmental-Nutrition-Smoking

Genetics

Susceptibility and protective genes are related to HLA
Monozygotic twins have a 30% concordance rate
Dizygotic twins have a 5% concordance rate
Non-twin siblings have a 2.5% concordance rate
Treatment response genes and genotype-phenotype relation are mentioned but not detailed

Epstein-Barr Virus Infection

A longitudinal analysis reveals a high prevalence of Epstein-Barr virus (EBV) associated with multiple sclerosis
Risk of MS increased 32-fold after EBV infection
There is not an increased risk after other infections such as cytomegalovirus
Neurofilament light chain biomarker elevated after EBV seroconversion

EBV Virus Mechanism

Uncontrolled latency and inflammatory cascade
Inflammatory B cell and EBNA1 peptides
CNS trafficking and autoreactivity
Molecular mimicry

EBV Critical Points

Infection timing is critical in genetically susceptible individuals
Age at infection impacts risk

Vitamin D and Multiple Sclerosis

Vitamin D is an immune modulator and gene regulator
Supplements are mandatory for MS patients by most experts
High-dose Vitamin D is safe in certain trials
Relationship between low Vitamin D levels, increasing lesions, and disability progression is confirmed

Immune-Pathogenesis in MS

Characterized by an imbalance between immunoregulatory and proinflammatory immune cells

Pathology

MS starts peripherally, then resides centrally and disables the blood-brain barrier (BBB), starting its destruction

Post-Mortem MS Brain

MS causes more extensive demyelination of the grey matter than the white matter

MS Plaques

Occur around veins in the brain and contain both lymphocytes and macrophages

MS Results in Demyelination

Demyelination occurs in both the brain and spinal cord

Clinical Presentation

Central: Fatigue, Cognitive Impairment, Depression, Unstable mood
Visual: Nystagmus, Optic neuritis, Diplopia
Speech: Dysarthria
Throat: Dysphagia
Musculoskeletal: Weakness, Spasms, Ataxia
Sensation: Pain, Hypoesthesias, Paraesthesias
Bowel: Incontinence, Diarrhea, Constipation
Urinary: Incontinence, Frequency, Retention

Optic Neuritis

Unilateral visual loss
Red vision affected first
Pain on eye movement
Pain typically doesn't last more than two weeks
Acute Optic Disc Swelling is a sign
Chronic Optic Disc Pallor is a sign

Brainstem/Cerebellar

Facial Palsy
Ataxia
Diplopia
Trigeminal neuralgia

Signs in Brain Stem Syndrome

Nystagmus: Description of eye movement
One-and-a-half syndrome: Description of eye movement
Ataxia: Description of body movement

Symptoms - Spinal Cord

Lhermitte's symptom
Numbness
Urinary Urgency
Faecal Incontinence
Sexual Dysfunction
Spastic paraplegia

Signs in Spinal Cord Syndrome

Weakness
Increased tone +/- clonus
Brisk reflexes
Upgoing plantar response

Signs in Spinal Cord Syndrome (Acute Transverse Myelitis)

Acute transverse myelitis in MS is usually partial
Involves more than three adjacent cord segments
Brown Sequard syndrome is a type of manifestation

Symptoms - Cerebral Hemispheres

Cognitive impairment
Hemiparesis
Seizures
Encephalopathy

Signs in Cerebral Hemisphere Syndrome

Description of symptoms on each side of the brain

Acute Attack

Usually more than 24 hours
Subacute presentation
Optic neuritis, acute transverse myelitis, brainstem and cerebellar syndromes, and pyramidal syndromes

Course of MS

Multifocal inflammation of brain and spinal cord
Neuroaxonal degeneration
Relapsing-remitting, primary progressive, and secondary progressive

Types of Multiple Sclerosis

Descriptions of graphs showing progression of symptoms and disability over time for each type

Diagnosis

No single diagnostic test
McDonald criteria (2017) combines clinical, MRI, and ancillary tests
Excludes MS mimics (vasculitis, autoimmune disease), vitamin B12 deficiency, and NMOSD
Dissemination in time and space is essential

MRI

Describes different types of lesions seen on brain MRI

2017 McDonald Criteria

Criteria for diagnosis of MS

Diagnosis of PPMS

One year of disease progression (retrospectively or prospectively confirmed)
Plus two of three following: evidence of DIS on brain MRI, evidence of DIS in the cord, positive unmatched OCBs in the CSF

CIS & RIS

Clinically Isolated Syndrome (CIS) is the initial episode of demyelination
Radiologically Isolated Syndrome (RIS) is the presence of MRI findings of MS in an asymptomatic patient

Prognosis

Proportion of wheelchair-bound patients after diagnosis of relapsing-remitting MS (RRMS)
Dependency projected in RRMS cases after 25 years

MS Progression

Graph of Expanded Disability Status Scale (EDSS), tracking progression over time from clinical onset

Treatment

Acute Attack: Methylprednisolone 5-day course +/- plasma exchange
Maintenance: Disease-specific and symptomatic

Disease-Specific Treatment

Strategies: Wait and see, Hit early, Shift early, Hit strong from the start
Describes different philosophies about timing and intensity of treatment
Techniques such as time-lapse MRI

Treatment Agents

List of disease-modifying therapies
Detailed descriptions of how each medication addresses MS

Interferon Beta 1

Four formulations
Yearly relapse reduction, disability reduction
Injectable

Glatiramer Acetate

Comparable relapse rate (to interferon)
No effect on disability
Injectable

Natalizumab

High reduction of relapse rate and disability
Injectable every 4 weeks
Safety issue of PML (Progressive Multifocal Leukoencephalopathy)

Fingolimod

Oral tablet drug
Unique mechanism of action
Reduces annual relapse rate (vs placebo and interferon)
Improves MRI parameters
Requires admission for initial dose

Siponimod

Oral daily S-1-P modulator
Efficacy and side-effect profile similar to fingolimod, for RRMS and SPMS

Teriflunomide

Oral
comparable relapse rate reduction to interferon
Side effects of alopecia and non-life threatening infection
Teratogenic in both males and females

Dimethyl Fumarate

Oral capsule
Immune modulator and neuroprotective
Relapse rate reduction 45%
Positive effects on disability and MRI parameters
Side effects acceptable, though PML reported

PEG Interferon and High-Dose GA

Improvements in study design and adherence among patients

Alemtuzumab

Anti CD52
Infusion, 5 days, then three days each year
Side effects include ITP, Thyroid disease, and neoplastic processes.
Serious infections are another possible complication
Treatment for severe non-responsive cases of MS

Anti CD20

Rituximab (off label) or Ocrelizumab (approved) every 6 months for RRMS
Ofatumumab monthly self-injectable, approved for RRMS & CIS
Side effect profile includes possible infusion reactions and infections
Comparative clinical trials (RCT)

Cladribine

Chemotherapeutic agent
Immune reconstitution
Oral 5-day course annually
Side effects such as cytopenia and infection

Future Treatments

Intra-thecal anti-CD20 therapy
Stem cell transplant
Bruton tyrosine kinase inhibitors
Anti-CD19 monoclonal antibodies

Once Was a Dream...

Visual representation of normal and demyelinated nerve function, and remyelination via therapy

COVID and MS

MS patients are no more likely to get COVID
COVID prognosis worse in cases with more disability
Vaccination against Covid safe and can be coordinated with MS medications, where appropriate

Thanks for Listening

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Description

Explore the complexities of Multiple Sclerosis (MS), an autoimmune condition affecting the central nervous system. This quiz covers key aspects such as epidemiology, etiology factors, and management strategies. Test your knowledge on the demographics, prevalence, and influencing factors of MS.